Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	35.29	-5.60	-8.65
Graham Fair Price	41.21	6.20	4.39
PEG	-75.62	-0.02	0.08
Price/Book	34.43	3.96	2.95
Price/Cash Flow	28.64	-13.87	-19.43
Prices/Earnings	32.79	-1.80	-2.67
Price/Sales	-32.79	95.39	141.92
Price/FCF	28.64	-13.87	-19.43
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-57.03	-0.13	0.30
Operating Margin	-16.90	-15.69	-13.42
ROA	-100.00	-0.26	-0.13
ROE	-0.28	-0.55	-100.00
ROIC	-0.17	-0.40	-133.63
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.10	-0.01	850.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.49	-1.34	170.82
EPS QOQ	0.36	-0.98	175.74
FCF QOQ	0.77	-0.88	14.62
Revenue QOQ	-0.69	1.00	44.60
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	57.58	17.81	-69.06
Days Sales Outstanding (DSO)	1093.55	657.00	-39.92
Inventory Turnover	1.56	5.05	223.23
Debt/Capitalization	0.39	0.30	-21.52
Quick Ratio	2.56	2.65	3.53
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1.76	1.76	-0.15
Cash	2.10	2.09	-0.15
Capex	-0.03	-0.05	-100.03
Free Cash Flow	-0.27	-0.50	-88.09
Revenue	0.04	0.07	99.70
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.78	2.78	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.02	0.81	-60.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating